StonvexLoading…
StonvexStonvexStonvexCore line items from DTIL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $10.84M | $34.26M | $60.00K | $47.00K |
Operating Income | $-9.07M | $-52.15M | $-64.66M | $-43.99M |
Net Income | $-18.44M | $-45.72M | $-65.86M | $-23.52M |
EPS (Diluted) | $-0.75 | $-3.56 | $-6.14 | $-4.33 |
Total Assets | $143.89M | $154.42M | $93.51M | $108.93M |
Total Liabilities | $67.79M | $62.17M | $76.88M | $74.87M |
Cash & Equivalents | $99.37M | $110.82M | $44.87M | $62.24M |
Free Cash Flow OCF − CapEx | $-11.96M | $-65.93M | $-54.66M | $-39.39M |
Shares Outstanding | 25.81M | 24.09M | 12.08M | 11.64M |